Anthem Biosciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026

ANTHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+4.0%1-day move

₹663.95

prior close

₹663.45

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.9-0.6-0.5-0.7+4.0+8.4+12.4+9.6+9.9+9.2+16.0+17.5+16.6+15.2

Up moveDown movePending

AI summary

Anthem Biosciences Limited has submitted a compliance certificate under SEBI Regulation 74(5) for Q4 FY26 (ending March 31, 2026). The certificate from their Registrar and Transfer Agent, Kfin Technologies Limited, confirms that details of securities dematerialized and rematerialized during the quarter have been properly furnished to both NSDL and CDSL (the two depositories) and all relevant stock exchanges. This is a mandatory quarterly filing to ensure compliance with SEBI's depository regulations. The company was listed on both BSE and NSE in early 2025.

Likely market impact

No direct impact on shareholders or stock price. This is a routine regulatory compliance confirmation with no material implications for investors.